Inventor
SANTELLA III JOSEPH B
US26 patents
⚠️ This page may combine multiple inventors who share the name “SANTELLA III JOSEPH B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB PHARMA CO
16 patentsUS6759411B2Jul 6, 2004
Heterocyclic piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO26 citations92
US6605623B1Aug 12, 2003
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO36 citations92
US6521592B2Feb 18, 2003
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO28 citations92
US6441001B1Aug 27, 2002
2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO26 citations92
US6492400B1Dec 10, 2002
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO15 citations84
US6864380B2Mar 8, 2005
Benzylcycloalkyl amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO5 citations74
US6780857B2Aug 24, 2004
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO6 citations73
US6486180B1Nov 26, 2002
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO10 citations72
US7126010B2Oct 24, 2006
Benzylcycloalkyl amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO2 citations63
US6960666B2Nov 1, 2005
Bicyclic and tricyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO2 citations63
US6784200B2Aug 31, 2004
Bicyclic and tricyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO4 citations63
US6706735B2Mar 16, 2004
2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations63
US6906066B2Jun 14, 2005
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations61
US6875776B2Apr 5, 2005
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations61
US6897234B2May 24, 2005
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations55
US7312222B2Dec 25, 2007
Heterocyclic piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO0 citations52
DU PONT MERCK PHARMA
3 patentsUS5563127AOct 8, 1996
Boronic acid and ester inhibitors of thrombin
DU PONT MERCK PHARMA74 citations95
US5545651AAug 13, 1996
Imidazole 5-position substituted angiotensin II antagonists
DU PONT MERCK PHARMA16 citations72
US5395844AMar 7, 1995
Imidazole 5-position substituted angiotensin II antagonists
DU PONT MERCK PHARMA10 citations72